Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain

Neuropeptides

Volumn 40, Issue 2, 2006, Pages 115-123

  Lin, Shu ^a   Boey, Dana ^a   Lee, Nicola ^a   Schwarzer, Christoph ^b   Sainsbury, Amanda ^a   Herzog, Herbert ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Dynorphin; In situ hybridisation; Neuropeptide Y

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y; PRODYNORPHIN;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARCUATE NUCLEUS; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN REGION; CAUDATE NUCLEUS; HIPPOCAMPUS; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IN SITU HYBRIDIZATION; LATERAL RETICULAR NUCLEUS; MALE; MESENCEPHALON; MOUSE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PUTAMEN; SOLITARY TRACT NUCLEUS; SUPRAOPTIC NUCLEUS; THALAMUS;

ANIMALS; BRAIN; ENKEPHALINS; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; PROTEIN PRECURSORS; RNA, MESSENGER;

ANIMALIA;

EID: 33646129214     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2005.11.006     Document Type: Article

References (36)

1. Abe J., Okamura H., Kitamura T., Ibata Y., Minamino N., Matsuo H., and Paull W.K. Immunocytochemical demonstration of dynorphin(PH-8 P)-like immunoreactive elements in the human hypothalamus. Journal of Comparative Neurology 276 (1988) 508
2. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., and Herzog H. Hypothalamic Y2 receptors regulate bone formation. Journal of Clinical Investigation 109 (2002) 915
3. Cowen M.S., Rezvani A., Jarrott B., and Lawrence A.J. Distribution of opioid peptide gene expression in the limbic system of Fawn-Hooded (alcohol-preferring) and Wistar-Kyoto (alcohol-non-preferring) rats. Brain Research 796 (1998) 323
4. Curran E.J., and Watson Jr. S.J. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: A double in situ hybridization study. Journal of Comparative Neurology 361 (1995) 57
5. Elias C.F., Kelly J.F., Lee C.E., Ahima R.S., Drucker D.J., Saper C.B., and Elmquist J.K. Chemical characterization of leptin-activated neurons in the rat brain. Journal of Comparative Neurology 423 (2000) 261
6. Elias C.F., Lee C.E., Kelly J.F., Ahima R.S., Kuhar M., Saper C.B., and Elmquist J.K. Characterization of CART neurons in the rat and human hypothalamus. Journal of Comparative Neurology 432 (2001) 1
7. Fallon J.H., and Leslie F.M. Distribution of dynorphin and enkephalin peptides in the rat brain. Journal of Comparative Neurology 249 (1986) 293
8. Franklin K.B., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
9. Glass M.J., Billington C.J., and Levine A.S. Opioids and food intake: Distributed functional neural pathways?. Neuropeptides 33 (1999) 360
10. Goldstein A., Tachibana S., Lowney L.I., Hunkapiller M., and Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proceedings of the National Academy of Sciences of the United States of America 76 (1979) 6666
11. Graybiel A.M. Neuropeptides in the basal ganglia. Research Publications - Association for Research in Nervous and Mental Disease 64 (1986) 135
12. Hurd Y.L. Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex. Molecular Psychiatry 7 (2002) 75
13. Khachaturian H., and Watson S.J. Some perspectives on monoamine-opioid peptide interaction in rat central nervous system. Brain Research Bulletin 9 (1982) 441
14. Khawaja X.Z., Chattopadhyay A.K., and Green I.C. Increased beta-endorphin and dynorphin concentrations in discrete hypothalamic regions of genetically obese (ob/ob) mice. Brain Research 555 (1991) 164
15. Lambert P.D., Wilding J.P., al-Dokhayel A.A., Bohuon C., Comoy E., Gilbey S.G., and Bloom S.R. A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. Endocrinology 133 (1993) 29
16. Laughlin T.M., Larson A.A., and Wilcox G.L. Mechanisms of induction of persistent nociception by dynorphin. Journal of Pharmacology and Experimental Therapeutics 299 (2001) 6
17. Meister B., Villar M.J., Ceccatelli S., and Hokfelt T. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: An immunohistochemical study using experimental manipulations. Neuroscience 37 (1990) 603
18. Merchenthaler I., Maderdrut J.L., Cianchetta P., Shughrue P., and Bronstein D. In situ hybridization histochemical localization of prodynorphin messenger RNA in the central nervous system of the rat. Journal of Comparative Neurology 384 (1997) 211
19. Miura M., Inui A., Sano K., Ueno N., Teranishi A., Hirosue Y., Nakajima M., Okita M., Togami J., Koshiya K., et al. Dynorphin binds to neuropeptide Y and peptide YY receptors in human neuroblastoma cell lines. American Journal of Physiology 267 (1994) E702
20. Morris B.J., Haarmann I., Kempter B., Hollt V., and Herz A. Localization of prodynorphin messenger rna in rat brain by in situ hybridization using a synthetic oligonucleotide probe. Neuroscience Letters 69 (1986) 104
21. Morris B.J., Hollt V., and Herz A. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: Contrasting effects of D1 and D2 antagonists. Neuroscience 25 (1988) 525
22. Morris B.J., and Johnston H.M. A role for hippocampal opioids in long-term functional plasticity. Trends in Neuroscience 18 (1995) 350
23. Nakao K., Yoshimasa T., Oki S., Tanaka I., Nakai Y., Wakimasu M., Fujino M., and Imura H. Presence of dynorphin-like immunoreactivity in rat pituitary gland and hypothalamus. Regulatory Peptides 2 (1981) 201
24. Neal Jr. C.R., and Newman S.W. Prodynorphin peptide distribution in the forebrain of the Syrian hamster and rat: A comparative study with antisera against dynorphin A, dynorphin B, and the C-terminus of the prodynorphin precursor molecule. Journal of Comparative Neurology 288 (1989) 353
25. Palkovits M. Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons. European Journal of Pharmacology 405 (2000) 161
26. Przewlocki R., Lason W., Konecka A.M., Gramsch C., Herz A., and Reid L.D. The opioid peptide dynorphin, circadian rhythms, and starvation. Science 219 (1983) 71
27. Romualdi P., Lesa G., and Ferri S. Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain. Brain Research 563 (1991) 132
28. Rossier J. Opioid peptides have found their roots. Nature 298 (1982) 221
29. Sahu A., Kalra P.S., and Kalra S.P. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9 (1988) 83
30. Sainsbury A., Schwarzer C., Couzens M., and Herzog H. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51 (2002) 3420
31. Sato M., Morita Y., Saika T., Fujita M., Ohhata K., and Tohyama M. Localization and ontogeny of cells expressing preprodynorphin mRNA in the rat cerebral cortex. Brain Research 541 (1991) 41
32. Schulz S., Schreff M., Nuss D., Gramsch C., and Hollt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain modulatory brain regions. Neuroreport 7 (1996) 3021
33. Shippenberg T.S., and Rea W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacology Biochemistry and Behavior 57 (1997) 449
34. Shirayama Y., Ishida H., Iwata M., Hazama G.I., Kawahara R., and Duman R.S. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. Journal of Neurochemistry 90 (2004) 1258
35. Simonato M., and Romualdi P. Dynorphin and epilepsy. Progress in Neurobiology 50 (1996) 557
36. Smart D., and Jerman J. The physiology and pharmacology of the orexins. Pharmacology and Therapeutics 94 (2002) 51